Device vs manual pressure for closing blood vessels after AFib procedure
Part of Heart & circulation clinical trials.
This study compares two ways to close the vein entry after heart ablation for AFib: the LockeT device versus manual compression. It helps find which method works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for a planned heart procedure (like AFib ablation) that needs a vein puncture.
- Your doctor will use the LockeT device or manual compression to close the vein.
- You can give your consent and follow the study rules.
- You are not pregnant (if you are of childbearing age, a pregnancy test will be done).
- There is no hematoma (bruise from bleeding) noticed before closing the vein.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a special steerable catheter tool can improve successful closure of the left atrial appendage (a heart pocket linked to stroke risk) in people with atrial fibrillation. It may help doctors place the closure device more successfully.
This study compares two methods to close the blood vessel after a catheter ablation for atrial fibrillation (AF). It may help reduce bleeding or other problems at the access site.
This trial tests the Zenith system, a device that seals off a heart area called the left atrial appendage to reduce stroke risk in people with atrial fibrillation (AF). You may be eligible if you have AF and a doctor recommends LAA closure, and you can return for follow-up scans and visits.
This study looks at whether a lower-dose blood thinner works as well as the usual recommended anti-clot treatment after a procedure that closes off the heart’s left atrial appendage. It may help reduce bleeding risk while still preventing dangerous blood clots.
This trial tests whether patients who receive a special device to close a hole in the heart (to prevent stroke from irregular heartbeat) can safely take fewer blood-thinning medications afterward. The study compares taking a standard blood thinner for 3 months versus taking aspirin only, to see which approach works best with fewer bleeding risks.
This study is testing a minimally invasive procedure to close off a part of the heart (the left atrial appendage) in people with kidney failure on dialysis who also have atrial fibrillation. The goal is to reduce the risk of stroke without needing long-term blood thinners.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.